Company Filing History:
Years Active: 2019
Title: Christopher Robert Bland: Innovator in Pharmaceutical Formulations
Introduction
Christopher Robert Bland is a notable inventor based in Kent, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release formulations. His innovative approach has the potential to enhance the effectiveness of drug delivery systems.
Latest Patents
Christopher holds 1 patent for his work on delayed release pharmaceutical formulations. This patent focuses on controlling the release of a drug by formulating it with a disruption agent, which is then coated with a regulatory membrane. This membrane consists of a water-soluble gel-forming polymer and a water-insoluble film-forming polymer, allowing for a delayed release after administration.
Career Highlights
Christopher is currently associated with Euro-Celtique S.A., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Christopher has collaborated with notable professionals, including Derek Allan Prater and Mohammed Hassan. These collaborations have further enriched his work and contributed to advancements in pharmaceutical technology.
Conclusion
Christopher Robert Bland's contributions to delayed release pharmaceutical formulations exemplify the impact of innovation in the medical field. His work continues to influence drug delivery systems, showcasing the importance of research and development in pharmaceuticals.